Published 12-01-08
Submitted by GBCHealth
New York, NY. - December 1, 2008 - CEOs from companies including Chevron, Dell, ExxonMobil, Heineken, Coca-Cola, Gap and Nike today made an unprecedented pledge to end workplace HIV discrimination and stigma in their companies.
In all, more than 100 members of the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria made the historic commitment - reaching approximately five million employees around the world.
Eradicating stigma and discrimination is critical to defeating HIV/AIDS, which has claimed more than 25 million lives.
"Stigma and discrimination kill," said Coalition President and CEO Richard Holbrooke. "They keep people from getting tested, and from getting care and support if they need it. Ending stigma is one of the most effective things anyone can do to stop AIDS.
"By making its powerful voice clear, business is providing much needed leadership which will, in turn, influence the behavior and actions of other businesses, governments and individuals," Holbrooke continued. "Collective, coordinated action on AIDS, and business action, is critical. It's impossible to win the fight without it."
The signatories' action delivered a clear message that their companies are taking concrete action to end HIV/AIDS. Workplace policies increase the rate of HIV testing and treatment, and corporate attitudes often have significant impact on communities, governments and business partners.
To learn more about the Coalition and its drive to mobilize the power of business to achieve bigger results in the fight against AIDS, TB and Malaria visit:
http://www.gbcimpact.org/live/feature/strategy.php
The full list of CEO signatories to the pledge follows:
Miles D. White, Abbott
Aigboje Aig-Imoukhuede, Access Bank Plc
Gilles Pelisson, Accor
Cynthia Carroll, Anglo American plc
Margery Kraus, APCO Worldwide
Anne Lauvergeon, AREVA Group
Kabelo Antony Ebineng, Associated Fund Administrators Botswana (Pty) Ltd
David R Brennan, AstraZeneca
Rahul Bajaj, Bajaj Auto
Peter Munk, Barrick Gold Corporation
Werner Wenning, Bayer AG
Edward J. Ludwig, BD (Becton, Dickinson and Company)
Vimal B.Shah, Bidco Oil Refineries Limited
Stephane Bancel, bioMerieux
Birger Sorensen, Bionor Immuno
Debra L. Lee, Black Entertainment Television (BET)
William Downe, BMO Financial Group
Dr. Alessandro Banchi, Boehringer Ingelheim
Shumeet Banerji, Booz & Company
Tony Hayward, BP
Michael T. Dan, The Brink's Company
James Cornelius, Bristol-Myers Squibb
Michael Predeaux, British American Tobacco
Mark Penn, Burson-Marsteller
Dave O'Reilly, Chevron Corporation
Gerald T. McCaughey, CIBC
Vikram Pandit, Citigroup
Muhtar Kent, The Coca-Cola Company
Samer Khoury, Consolidated Contractors International Company S.A.L. (CCC)
Dr. Dieter Zetsche, Daimler AG
N. F. Oppenheimer, De Beers
Blackie Marole, Debswana
Michael Dell, Dell
James H. Quigley, Deloitte Touche Tohmatsu
Gerald Mahinda, East African Breweries Limited
Gennady Gazin, EastOne LLC
Richard Edelman, Edelman
Christian Kemp Griffin, EDUN
John Lechleiter, Eli Lilly and Company
Phirwa Jacob Maroga, Eskom
Martin Vial, Europ Assistance Holding
Rex Tillerson, Exxon Mobil Corporation
Jacqueline Mugo, Federation of Kenyan Employers
Glen K. Murphy, Gap Inc.
Jonathan D. Klein, Getty Images
Alexander Saint-Amand, Gerson Lehrman Group
Andrew P. Witty, GlaxoSmithKline
Dong Soo Hur, GS Caltex Corporation
P. Igathe, Haco Industries Ltd
William A. Haseltine, Haseltine Global Health
Jean-Francois van Boxmeer, Heineken N.V.
Richard Plepler, Home Box Office (HBO)
Victor Y. Yuan, Horizon Research Group
Frank Ireri, Housing Finance Company of Kenya Limited
Anthony L. Howard, Independent Newspapers (Pty) Ltd
Heather Reisman, Indigo Books & Music Inc.
Corrado Passera, Intesa Sanpaolo
Jena Gardner, JG Black Book of Travel
William C. Weldon, Johnson & Johnson
Gerard J. Inzerillo, Kerzner International
Derek J. Oatway, KK Security (Kenya Kazi Services Ltd)
Bruno Lafont, Lafarge
John Anderson, Levi Strauss & Co.
Beatrice Dautresme, L'Oréal
John Demsey, MAC Cosmetics / MAC AIDS Fund
Ian E.L. Davis, McKinsey & Company
Richard Clark, Merck & Co., Inc.
L W Nkuhlu, Metropolitan
Dennis Pinto, Micato Safaris
Samir Modi, Modicare
William H. Roedy, MTV Networks
Robert J. Coury, Mylan Inc.
Gary Ginsberg, News Corporation
Mark Parker, Nike, Inc.
David Stern, National Basketball Association (NBA)
Daniel Vasella, M.D., Novartis
Duncan L. Niederauer, NYSE Euronext, Inc.
Marcia Silverman, Ogilvy Public Relations Worldwide
Douglas A Michels, OraSure Technologies
Jeff Kindler, Pfizer Inc.
Christie Hefner, Playboy Enterprises Inc.
Naresh S. Mehta, Power Technics
Neil Mehta, Premier Medical Corporation
Maurice Levy, Publicis
Malvinder Mohan Singh, Ranbaxy Laboratories Limited
Thomas H. Glocer, Reuters
Tom Albanese, Rio Tinto
Simon Cooper, The Ritz-Carlton Hotel Company
Gordon M. Nixon, Royal Bank of Canada
Dr. Ganesh P. Rane, RRR Industries
Matthew J. Wright, Russell Reynolds Associates
Graham Mackay, SABMiller plc
Fred Hassan, Schering-Plough Corporation
Rick Waugh, Scotiabank Group
Ai Lianghua, Shanghai Desano Pharmaceuticals Holding Company Ltd
Pete Ruegger, Simpson, Thacher & Bartlett
Christian Jourquin, Solvay
Gary Watts, SSL International plc
Clive Tasker, Standard Bank
Peter Sands, Standard Chartered Bank
Hiromasa Yonekura, Sumitomo Chemical
Scott Mullin, TD Bank Financial Group
Carol Johnston, Times Media Group
Christophe de Margerie, Total
John Noel, Travel Guard
Marie-Christine de Saragosse, TV5
Patrick Cescau, Unilever
Henri Proglio, Veolia Environment
Mikkel Vestergaard Frandsen, Vestergaard Frandsen
Phillippe Dauman, Viacom International
Sir Richard Branson, Virgin
Martin Winterkorn, Volkswagen
S. Shiryaev, Vostok-Service
Lev Partskhaladze, XXI Century Investments
Mick Davis, Xstrata
Dr. Subhi Quraishi, ZMQ Software Systems
Global Business Coalition on HIV/AIDS, TB and Malaria
The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria is a coalition of more than 220 companies united to keep the fight against these epidemics a global priority. The Coalition provides tailored support so that companies can take an active role in defeating the pandemics. The Coalition also organizes collective actions among companies and links the public and private sectors in ways that pool talents and resources. The official focal point of the private sector delegation to the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Coalition maintains offices in New York, Paris, Johannesburg, Beijing, Nairobi and Moscow. For more information visit: http://www.gbcimpact.org
GBCHealth is the preeminent organization focused on business engagement in support of meeting global goals for health. Its vision is health equity and a global business community that contributes its assets, skills, influence and reach to create a healthier world for employees, their families, and communities. GBCHealth works with companies worldwide and with the United Nations, governments, academia, civil society & others. In September 2022, GBCHealth launched future united, a global initiative harnessing the power of the private sector to fight for - and achieve - health equity, tackle the impact of climate change on health, and address antimicrobial resistance and future pandemics.
More from GBCHealth